Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Aug 17, 2021 12:23pm
35 Views
Post# 33717223

RE:RE:RE:RE:RE:RE:RE:RE:RE:Be patient Gunner...did u see friday after hours

RE:RE:RE:RE:RE:RE:RE:RE:RE:Be patient Gunner...did u see friday after hoursMore from the pumping scammer on pumping friday after hours

Newcamo wrote:

+ they are full of cash, buy here, be in when it reverses on news and analysts after non dilutive cash infusion of 100M$. The reverse will be brutal , market cap only 75M$

 

tommyjones0 wrote:

 

For the readers, beware the scammers on this board here everyday with their doom and gloom...they are accumulating like the rest of us, read the latest NR , or the last part of this message below.

 

Mariadelapena wrote: Same opinion here. Market cap 75M$. In du time, this stock will move up several time, more than 120M$ in cash, full pipeline, we have to wait for the analysts upgrades and news. Buy, hold, sell between 7$-10$...

 

captsecord wrote:

They take it down, they take it up, i've seen it a million times. Spammers on this board "hating" the stock are accumulating like we all are. It's buy time like we saw friday after hours....

 

Mariadelapena wrote:

 

after hours friday indicates good news... they are du for an operational update, they have a pipeline and they have  money now. Be patient. Analysts will update their targets, and that will be up 100%. They might wait for the operational update though.

News incoming obviously! volume 1M after hours...something is up...

Good financials or good news or both.........

at one point we were +20% after hours......something is coming. Patience is a virtue

Mama Maria.

--------------------------------------------------------------------------------------------------------

from latest nr:

 

...

"We are pleased to announce the sale of the PRV, which will provide an important source of non-dilutive capital to advance the continued development of our small molecule pipeline," said Bruce Pritchard, CEO of Liminal BioSciences. "This transaction is also another key milestone in completing the divestiture of our remaining plasma-derived therapeutics business to Kedrion."

Mr. Pritchard added, "Our priorities now are to move to a full analysis of the complete PK data set from the phase 1 multi-ascending dose clinical trial for fezagepras, which will help determine the choice of any other potential indications for further development with that compound, as well as continuing with the development of our GPR84 and OXER1 programs. We look forward to providing a more comprehensive update on these programs in due course."

 

https://stockhouse.com/news/press-releases/2021/08/09/liminal-biosciences-announces-sale-of-priority-review-voucher-for-usd105m


 


 

 

 




<< Previous
Bullboard Posts
Next >>